GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Evonile Pharma Ltd

Evonile Pharma sets Nov 11 record date for INR 8,847.54 million rights issue

FUNDRAISE ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 04 Nov 2026, 07:08 PM IST  ·  BSE ID: 799bf3f4-61e2-4792-b2f3-3e2e968a358e
View Original BSE Filing (PDF)
💡
In Simple Terms
Evonile Pharma is issuing new shares to existing owners to raise funds, with November 11th being the date to check who gets to buy them.
🤖 AI Summary
  • Evonile Pharma sets November 11, 2026 record date for INR 8,847.54 million rights issue.
  • Company to issue 1,02,87,832 partly paid equity shares at INR 860 each.
  • Rights issue opens November 19, 2026, and closes December 03, 2026.
  • Record date to determine eligibility of existing shareholders for the rights offering.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Record Date
November 11, 2026
Total number of securities proposed to be issued
1,02,87,832
Issue Price
INR 860 /-
Issue Size
INR 8,847.54/- Million
Rights Issue Opening Date
November 19, 2026
Rights Issue Closing Date
December 03, 2026
🏢 How This Affects the Company
📈
Business Impact
The rights issue will provide Evonile Pharma with significant capital, enabling potential expansion or strategic initiatives. The exact use of funds will shape future business development.
💰
Financial Impact
The company will raise INR 8,847.54 million, enhancing its cash reserves and equity base. The partly paid nature of shares means funds will be received in tranches.
⚠️
Risk Impact
A rights issue can dilute existing shareholder holdings if they do not subscribe. Management's plan for deploying the raised capital will influence long-term risk.
👥 What This Means For Shareholders
✅
Action Required
Shareholders as of November 11, 2026, will receive rights to subscribe to new partly paid equity shares. Specific action details for subscription will follow.
👤
Who Is Affected
Eligible equity shareholders as of November 11, 2026, will be entitled to subscribe to 5 Rights Equity Shares for every 12 fully paid-up Equity shares held.
🔍
Management Signal
The company is signaling a need for significant capital infusion, indicating plans for growth or strategic financial maneuvers.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Confirmation of final allotment basis for the rights issue.
Schedule for payment of first and final call on partly paid shares.
Announcement on the utilization of funds raised from the rights issue.
MEDIUM RISK Rights issue introduces dilution risk and requires timely capital calls from partly paid shareholders.
💡 Investor Takeaway
Evonile Pharma has set November 11, 2026, as the record date for its rights issue of 1,02,87,832 partly paid equity shares at INR 860 each, aiming to raise INR 8,847.54 million.
⚖️ Strengths & Concerns

✅ Positives

  • Record date set for November 11, 2026, facilitating timely rights issue execution.
  • Issue size of INR 8,847.54 million provides substantial capital for company initiatives.

⚠️ Concerns

  • Partly paid shares require subsequent calls, impacting cash flow management for investors.
  • Rights Issue closes December 03, 2026, requiring timely action from eligible shareholders.
❓ Frequently Asked Questions
What is the record date for Evonile Pharma's rights issue?
The record date for Evonile Pharma's rights issue is November 11, 2026, to determine eligible shareholders.
What is the total issue size of Evonile Pharma's rights issue?
The total issue size for Evonile Pharma's rights issue is INR 8,847.54 Million.
What is the issue price per share for the Evonile Pharma rights issue?
The issue price per partly paid equity share for Evonile Pharma's rights issue is INR 860.
When does the Evonile Pharma rights issue open and close?
The Evonile Pharma rights issue opens on November 19, 2026, and closes on December 03, 2026.
How many shares will Evonile Pharma issue in its rights issue?
Evonile Pharma will issue 1,02,87,832 partly paid equity shares in its rights issue.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.